Related Experiment Video

Updated: Jun 17, 2026

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
04:43

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

Bilirubin rebound after intensive phototherapy for neonatal jaundice

Anuradha Bansal1, Suksham Jain, Veena R Parmar

  • 1Department of Pediatrics, Government Medical College Hospital, Chandigarh, India.

Indian Pediatrics
|December 19, 2009
PubMed

Insights

A small percentage of newborns (7.3%) experience significant bilirubin rebound after phototherapy. Key risk factors for this rebound include prematurity and late jaundice onset, guiding post-discharge care.

Area of Science:

  • Neonatal Medicine
  • Pediatrics
  • Clinical Research

Background:

  • Hyperbilirubinemia is common in newborns.
  • Phototherapy is a standard treatment.
  • Post-phototherapy bilirubin rebound requires monitoring.

Purpose of the Study:

  • To determine the incidence and magnitude of post-phototherapy bilirubin rebound.
  • To identify risk factors for significant bilirubin rebound (SBR).

Main Methods:

  • Prospective study of inborn neonates requiring phototherapy.
  • Bilirubin levels measured 24+/-6 hours after phototherapy cessation.
  • Significant bilirubin rebound (SBR) defined as bilirubin requiring phototherapy re-initiation.

Main Results:

  • 17 out of 232 neonates (7.3%) developed SBR.
  • Bilirubin increased by 2.3 mg/dL in neonates with SBR.
  • Risk factors for SBR included gestational age >35 weeks, birthweight <2000 g, and jaundice onset >60 hours.

Conclusions:

  • Significant bilirubin rebound occurs in a notable proportion of neonates.
  • Prematurity, low birthweight, and delayed jaundice onset are associated with SBR.
  • Discharge and follow-up planning should consider these identified risk factors.

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...